Fezolinetant is intended for Pharmaceuticals applications. It is an oral medication for the treatment of moderate to severe vasomotor symptoms, or hot flashes, caused by menopause. Fezolinetant is a neurokinin 3 (NK3) receptor antagonist approved by the FDA. All information about Fezolinetant is provided in the MSDS. We deliver compounds with high purity levels and a comprehensive Certificate of Analysis. Connect to your member account to consult the documents.

规格	1 mg
稳定性	≥ 1 year